Maybe if they'd pressed the accelerator year ago, it would have been a better story for the company and SHs.
Many bios today reported a range of results and licence deals. New kids on the block with better prospects in near term, IMO.
DXB....check that licence deal out
NEU...phase 2 results
EMV....algorithms for their mobile medical device
If you want to see what a modern day marketing plan looks like check BOT out.
- Forums
- ASX - By Stock
- Ann: Positive final DEP irinotecan Phase 2 clinical trial results
Maybe if they'd pressed the accelerator year ago, it would have...
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
12.0¢ |
Change
0.010(9.09%) |
Mkt cap ! $50.17M |
Open | High | Low | Value | Volume |
11.0¢ | 12.0¢ | 11.0¢ | $127.2K | 1.070M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 130918 | 11.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 103000 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 130918 | 0.110 |
8 | 208113 | 0.105 |
4 | 208569 | 0.100 |
2 | 10112 | 0.099 |
2 | 65110 | 0.098 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 103000 | 3 |
0.135 | 133794 | 6 |
0.140 | 139764 | 4 |
0.145 | 8500 | 1 |
0.150 | 126570 | 2 |
Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |